Sonepcizumab (Synonyms: LT 1009; Anti-Human S1P Recombinant Antibody) |
Catalog No.GC69926 |
Sonepcizumab (LT 1009) es un anticuerpo monoclonal completamente humanizado contra S1P. Sonepcizumab tiene potencial para la investigación de carcinoma renal metastásico (mRCC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1031360-18-5
Sample solution is provided at 25 µL, 10mM.
Review for Sonepcizumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Sonepcizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *